AND

Famvir (famciclovir)

Profile

Contact Information

Currently Enrolling Trials

    Show More

    General Information

    For the treatment of recurrent mucocutaneous herpes simplex infections in HIV-infected patients.

    Approval Date: 1999-01-01
    Company Name: SmithKline Beecham
    Back to Listings

    Upcoming Events

    Featured Products

    Featured Stories

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here